Literature DB >> 27041935

The pathology of unusual subtypes of prostate cancer.

Jing Li1, Zhe Wang1.   

Abstract

There are some current literatures describing the morphologic change of prostate carcinoma variants. Some subtypes do not respond to hormone deprivation therapy, for example adenosquamous and squamous cell carcinoma (SQCC), basaloid and adenoid cystic carcinoma (ACC), small cell carcinoma (SmCC), sarcomatoid carcinoma, urothelial carcinoma; some are defined in special Gleason grade, some develop different prognosis. So, it is very important to identify these rare subtypes to avoid misdiagnosis. In this review, we aim to describe the typical clinicopathological features of the rare variants of prostate cancer, including prostate acinar adenocarcinoma morphologic variants.

Entities:  

Keywords:  Prostate carcinoma; ductal; foamy; mucinous; neuroendocrine (NE); pseudo hyperplastic; squamous; subtype

Year:  2016        PMID: 27041935      PMCID: PMC4779761          DOI: 10.3978/j.issn.1000-9604.2016.01.06

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  52 in total

1.  Ductal ("endometrioid") adenocarcinoma of the prostate.

Authors:  C Colpaert; P Gentens; E Van Marck
Journal:  Acta Urol Belg       Date:  1998-12

2.  Signet-ring cell carcinoma of the prostate--always an aggressive lesion?

Authors:  D M England; A G Hejka
Journal:  Arch Pathol Lab Med       Date:  1992-08       Impact factor: 5.534

3.  Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.

Authors:  Jonathan I Epstein; Lars Egevad; Peter A Humphrey; Rodolfo Montironi
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

Review 4.  A comprehensive review of incidence and survival in patients with rare histological variants of prostate cancer in the United States from 1973 to 2008.

Authors:  D M Marcus; M Goodman; A B Jani; A O Osunkoya; P J Rossi
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-02-21       Impact factor: 5.554

5.  Sarcomatoid carcinoma of the prostate: a study of 42 cases.

Authors:  Donna E Hansel; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2006-10       Impact factor: 6.394

6.  Foamy gland adenocarcinoma of the prostate: incidence, Gleason grade, and early clinical outcome.

Authors:  Jena Hudson; Dengfeng Cao; Robin Vollmer; Adam S Kibel; Shaun Grewal; Peter A Humphrey
Journal:  Hum Pathol       Date:  2012-01-04       Impact factor: 3.466

7.  Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.

Authors:  Vignesh T Packiam; Sanjay G Patel; Joseph J Pariser; Kyle A Richards; Adam B Weiner; Gladell P Paner; David J VanderWeele; Gregory P Zagaja; Scott E Eggener
Journal:  Urology       Date:  2015-07-18       Impact factor: 2.649

8.  Aberrant expression of p63 in adenocarcinoma of the prostate: a radical prostatectomy study.

Authors:  Giovanna A Giannico; Hillary M Ross; Tamara Lotan; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

9.  Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.

Authors:  Ming Zhou; Zhong Jiang; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

10.  Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.

Authors:  Adeboye O Osunkoya; Donna E Hansel; Xinlai Sun; George J Netto; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394

View more
  4 in total

Review 1.  Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review.

Authors:  Bartosz Malinowski; Michał Wiciński; Nikola Musiała; Ilona Osowska; Mateusz Szostak
Journal:  Diagnostics (Basel)       Date:  2019-10-25

2.  Role of lncRNA MIAT/miR-361-3p/CCAR2 in prostate cancer cells.

Authors:  Tao Feng; Chunyu Song; Zhiyong Wu; Ke Zhao; Shenglan Ye
Journal:  Open Med (Wars)       Date:  2022-09-28

3.  Post-Brachytherapy Transformation of Prostatic Adenocarcinoma to Squamous Cell Carcinoma: A Cadaver Anatomy Case Report.

Authors:  John T D'Angelo; Neha Bhaskar; Cole Friedes; Mujtaba Husain
Journal:  Cureus       Date:  2019-11-18

Review 4.  Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes.

Authors:  Salvatore Cozzi; Lilia Bardoscia; Masoumeh Najafi; Andrea Botti; Gladys Blandino; Matteo Augugliaro; Moana Manicone; Federico Iori; Lucia Giaccherini; Angela Sardaro; Cinzia Iotti; Patrizia Ciammella
Journal:  Curr Oncol       Date:  2022-03-09       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.